Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01518621 : Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer
PhasePhase 2
AgesMin: 18 Years Max: 100 Years
Inclusion Criteria: Histologically or cytologically confirmed advanced non-small cell lung
cancer (NSCLC) meeting 1 of the following criteria:

- Newly diagnosed multiple brain metastases not suitable for first-line chemotherapy

- Relapsed NSCLC with newly diagnosed multiple brain metastases

- Relapsed NSCLC after second-line or more chemotherapy regimens with newly diagnosed
multiple brain metastases

- Diagnosis of brain metastases confirmed by MRI (or CT if MRI is not
available/possible) within the past 4 weeks

- Symptoms attributable to brain metastases

- Patients who have undergone craniotomy with incomplete resection are eligible

- Clinician's opinion that whole-brain radiotherapy (WBRT) will be beneficial

- ECOG PS 0-2

- Age above 18 years

- Serum bilirubin < 2 times upper limit of normal (ULN)

- AST and ALT < 2 times ULN (< 5 times ULN if liver metastases are present)

- Creatinine < 1.5 times ULN

- Able to take oral medication

- Not pregnant or nursing

- Negative pregnancy test

- Fertile patients must use effective contraception

- No other prior or concurrent malignant disease likely to interfere with study
treatment or comparisons

Exclusion Criteria:

- More than 3 sites (organ systems) of extracranial metastases

- Evidence of solitary brain metastasis on MRI that can be treated with surgical
resection, radiosurgery, or stereotactic radiotherapy

- Evidence of other significant laboratory finding or concurrent uncontrolled medical
illness, that in the opinion of the investigator, would interfere with study
treatment or results comparison or render the patient at high risk for treatment
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557